Literature DB >> 28478495

Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis.

S Mariotto1, F Andreetta2, A Farinazzo1, S Monaco1, S Ferrari3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28478495     DOI： 10.1007/s10072-017-2958-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis.

Authors:  Eric S Frechette; Lei Zhou; Steven L Galetta; Lei Chen; Josep Dalmau
Journal:  Neurology       Date:  2011-02-15       Impact factor: 9.910

Review 2.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

3.  Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.

Authors:  H Prüss; J Dalmau; L Harms; M Höltje; G Ahnert-Hilger; K Borowski; W Stoecker; K P Wandinger
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

4.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

5.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Authors:  Nuria Gresa-Arribas; Maarten J Titulaer; Abiguei Torrents; Esther Aguilar; Lindsey McCracken; Frank Leypoldt; Amy J Gleichman; Rita Balice-Gordon; Myrna R Rosenfeld; David Lynch; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-12-18       Impact factor: 44.182
  5 in total
  2 in total

Review 1.  Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature.

Authors:  Di Nan; Ying Zhang; Jinming Han; Tao Jin
Journal:  Neurol Sci       Date:  2021-01-07       Impact factor: 3.307

Review 2.  Advances in Potential Cerebrospinal Fluid Biomarkers for Autoimmune Encephalitis: A Review.

Authors:  Shuyu Zhang; Chengyuan Mao; Xinwei Li; Wang Miao; Junfang Teng
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.